Dr. Rebecca Previs is a board-certified gynecologic oncologist with expertise in women’s health, precision medicine and early phase clinical trials. Dr. Previs prioritizes her research in evaluating the immune contexture of molecular characterized uterine cancers and how biomarkers can inform prognosis and treatment response in patients with medically managed uterine cancers. She works collaboratively with experts in diverse fields including epidemiology, cancer biology, biomedical engineering, pathology, and immunology to address complex questions in the cancer care continuum. She has served on national clinical trial committees and continues to prioritize mentoring the next-generation of oncologists and scientists.
Prior to joining Labcorp as the Director of Medical Affairs, she was an Assistant Professor of Gynecologic Oncology at Duke Cancer Institute and Duke University School of Medicine. As the principal investigator of an externally-funded translational laboratory, her work focused on pre-clinical development of novel cancer therapies and tumor immune microenvironment.
Upon completion of her training, Dr. Previs joined the Division of Gynecologic Oncology at Duke University, where she operated on patients with newly diagnosed or suspected gynecologic cancers. Her clinical practice focused enrolling patients with recurrent cancer on early phase and immuno-oncology clinical trials. Becca maintains an adjunct faculty appointment at Duke within the Department of Obstetrics & Gynecology, Division of Gynecologic Oncology in Durham, North Carolina.
Dr. Previs obtained her medical degree from the University of Virginia where she first realized her passion for women’s health and caring for patients with cancer. She completed a residency in Obstetrics & Gynecology at Duke University Medical Center followed by a fellowship in gynecologic oncology at The University of Texas MD Anderson Cancer Center. During training, she completed a Master Biomedical Sciences from the University of Texas Graduate School of Biomedical Sciences.